KEGG   PATHWAY: map07056
Entry
map07056          Drug      Pathway                                
Name
Agents for Alzheimer-type dementia
Class
Pathway map
map07056  Agents for Alzheimer-type dementia
map07056

Compound
D00196  Physostigmine (USP)
D00670  Donepezil hydrochloride (JP18/USP)
D02068  Tacrine hydrochloride (USP)
D02173  Galantamine hydrobromide (JAN/USP)
D02418  Physostigmine salicylate (JAN/USP)
D02558  Rivastigmine tartrate
D03822  Rivastigmine (JAN/USP/INN)
D03826  Physostigmine sulfate (USP)
D04292  Galantamine (USAN/INN)
D04905  Memantine hydrochloride (JAN/USP)
D06202  Tramiprosate (USAN)
D07869  Donepezil (JAN/INN)
D08174  Memantine (INN)
D08555  Tacrine (INN)
D08867  Bapineuzumab (USAN/INN)
D08869  Begacestat (USAN/INN)
D09010  Tarenflurbil (USAN/INN)
D09377  Semagacestat (USAN/INN)
D09713  Gantenerumab (USAN/INN)
D09869  Avagacestat (USAN)
D09917  Latrepirdine (USAN/INN)
D09918  Latrepirdine dihydrochloride (USAN)
D10058  Solanezumab (USAN/INN)

DBGET integrated database retrieval system